Skip to main content
Signal8

Jones Cecilia

SEC insider (Form 3/4/5 filer). CIK 0001840056. Chief Financial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO). 29 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in CAMBRIDGE, MA.

Companies Jones Cecilia has filed insider reports for

  • AGIOS PHARMACEUTICALS, INC. (AGIO): Officer, Chief Financial Officer
Jones Cecilia profile photo

Jones Cecilia

CIK: 0001840056

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)11 (37.9%)

Position reduction

Option Exercises (M)12 (41.4%)

Derivative conversions

Awards (A)6 (20.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AGIOS PHARMACEUTICALS, INC. logo
AGIO

AGIOS PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (29 total)

  • AGIOS PHARMACEUTICALS, INC. logo
    AGIO

    AGIOS PHARMACEUTICALS, INC.

    Jun 18, 2026
    Award

    Restricted stock units

    Direct
    3K shares-
  • AGIOS PHARMACEUTICALS, INC. logo
    AGIO

    AGIOS PHARMACEUTICALS, INC.

    Jun 18, 2026
    Exercise

    Performance share units

    Direct
    3K shares-
  • AGIOS PHARMACEUTICALS, INC. logo
    AGIO

    AGIOS PHARMACEUTICALS, INC.

    Apr 2, 2026
    Exercise
    Direct
    8.5K shares-
  • AGIOS PHARMACEUTICALS, INC. logo
    AGIO

    AGIOS PHARMACEUTICALS, INC.

    Apr 2, 2026
    Sale
    Direct
    3.1K shares at avg. $34.71$109K
  • AGIOS PHARMACEUTICALS, INC. logo
    AGIO

    AGIOS PHARMACEUTICALS, INC.

    Mar 2, 2026
    Sale
    Direct
    1.7K shares at avg. $28.96$49K
  • AGIOS PHARMACEUTICALS, INC. logo
    AGIO

    AGIOS PHARMACEUTICALS, INC.

    Mar 2, 2026
    Exercise
    Direct
    4K shares-
  • AGIOS PHARMACEUTICALS, INC. logo
    AGIO

    AGIOS PHARMACEUTICALS, INC.

    Mar 2, 2026
    Exercise
    Direct
    2K shares-
  • AGIOS PHARMACEUTICALS, INC. logo
    AGIO

    AGIOS PHARMACEUTICALS, INC.

    Mar 2, 2026
    Sale
    Direct
    1.6K shares at avg. $28.96$46K
  • AGIOS PHARMACEUTICALS, INC. logo
    AGIO

    AGIOS PHARMACEUTICALS, INC.

    Mar 2, 2026
    Exercise
    Direct
    5.7K shares-
  • AGIOS PHARMACEUTICALS, INC. logo
    AGIO

    AGIOS PHARMACEUTICALS, INC.

    Mar 2, 2026
    Exercise
    Direct
    5.3K shares-

1-10 of 29